NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Megan SniecinskiChief Operating Officer2026-05-1489$167.94
$14.95kBuy
Alex NemiroffGeneral Counsel and Secretary2026-05-1478$167.94
$13.10kBuy
Lauren MastrocolaPrincipal Accounting Officer2026-05-14127$167.94
$21.33kBuy
Timothy Edwin KellyChief Financial Officer2026-05-14121$167.94
$20.32kBuy
Marcio SouzaChief Executive Officer2026-05-14126$167.94
$21.16kBuy
Megan SniecinskiChief Operating Officer2026-01-12885$275.74
$244.03kSell
Timothy Edwin KellyChief Financial Officer2026-01-12943$275.74
$260.02kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-12768$275.74
$211.77kSell
Lauren MastrocolaPrincipal Accounting Officer2026-01-12344$275.74
$94.85kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-10917$288.45
$264.51kSell

1 of 5

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP17.55%4,894,109$1.73BInsider
Janus Henderson Group PLC12.41%3,458,863$1.22BInstitution
Stefan Vitorovic10.54%2,939,329$1.04BInsider
Orbis Allan Gray Ltd8.87%2,472,480$871.87MInstitution
Holdings A. Novo8.76%2,442,080$861.15MInsider
Blackrock Inc8.34%2,324,929$819.84MInstitution
Fmr LLC7.75%2,160,943$762.01MInstitution
Adage Capital Management LP7.39%2,060,175$726.48MInsider
Perceptive Advisors LLC7.30%2,035,986$717.95MInstitution
Baker Bros Advisors LP6.29%1,753,198$618.23MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX69.29%30.71%Net SellingNet Buying
CYTK90.49%9.51%Net SellingNet Selling
KRYS79.95%20.05%Net SellingNet Selling
ABVX63.37%0.00%
NUVL77.75%22.25%Net SellingNet Selling

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 114.03% institutional shareholders, 50.55% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 17.55% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $1.71B.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.